It took twenty years and $4 billion in research and development, but next month the FDA is expected to approve a breakthrough drug for treating Hepatitis C.
Researches stopped a study on the daily antiretroviral pill, Truvada, after early data showed that just as many women on the pill as those on the placebo had become infected with HIV.
...While the oral form provided little protection against HIV, the subjects who applied the tenofovir gel daily greatly improved their tissue's ability to block the virus...
"Priligy has the potential to do as much for men's sexual health as Viagra, said Nitin Makadia, head of male sexual health at U.K.'s leading pharmacy, Lloydspharmacy. "It will give sufferers a chance to improve the quality of their relationships and their general well-being.